Axcelead Inc. is a holding company centered on the drug discovery platform business, which was established in April 2020 by the Drug Discovery Gateway Fund Investment Limited Partnership, of which WHIZ Partners serves as a general partner. Axcelead Drug Discovery Partners, Inc. (ADDP), the core company of Axcelead, is Japan’s first integrated drug discovery solution provider, which took over Takeda’s drug discovery platform business in July 2017 with the aim of promoting the drug discovery ecosystem in Japan and will make various contributions to healthcare globally.